Cell cycle checkpoints

Concept

Cell cycle checkpoints

T-099Home BU-307Threads regulation · information

Statement

Surveillance that guards against damaged division.

Why it matters

cell-cycle-mitosis describes the physical sequence of events by which a cell duplicates and divides its contents; this result addresses a different question — how the cell verifies, at several defined points along that sequence, that each step has actually been completed correctly before allowing the next one to begin. Checkpoints are the mechanistic reason a cell's genome usually stays intact from one division to the next despite the enormous number of things that can go wrong (DNA damage, incomplete replication, misattached chromosomes); their failure is one of the central themes running through the rest of this unit, since hallmarks-of-cancer lists checkpoint evasion among the defining capabilities a tumour must acquire, and oncogenes-tumour-suppressors together with this result supply the molecular machinery whose loss makes that evasion possible.

Because checkpoints are surveillance systems rather than steps of the cycle itself, understanding them requires thinking about the cell cycle not just as a sequence of events but as a sequence of events each gated by a monitoring mechanism capable of halting progression — the same regulatory logic (a sensor, a signal, and a response that either proceeds or arrests) recurs in DNA damage response outside the cell cycle and in checkpoint-like control systems throughout physiology.

Hypotheses

Progression through the cell cycle is driven by cyclin-dependent kinases (CDKs), whose activity requires binding to a cyclin partner whose concentration rises and falls at specific points in the cycle.Checkpoints work specifically by blocking or delaying this CDK activation (rather than by some entirely separate mechanism); without a CDK-based "engine" to arrest, there would be no single control point for a checkpoint signal to act on. Checkpoint proteins can sense specific, defined problems (unreplicated or damaged DNA; chromosomes not yet correctly attached to the spindle) and transmit a signal that halts cycle progression until the problem is resolved.Without a sensing mechanism specific to the actual error, the cell would have no way to distinguish a normally proceeding cycle from a dangerous one, and could not selectively arrest only when something has genuinely gone wrong. Checkpoint arrest is reversible: once the underlying problem is corrected, the block is lifted and the cycle resumes.This distinguishes checkpoint arrest from apoptosis (programmed cell death, apoptosis-in-development): if damage is too severe to repair, sufficiently prolonged or intense checkpoint signalling (notably via p53) can instead trigger the cell's permanent removal, rather than resumption of the cycle — the checkpoint and the decision to eliminate the cell are mechanistically linked but conceptually distinct outcomes.

Proof

\text{G1/S checkpoint: verifies cell size, nutrient availability and DNA integrity before committing to replication.}

The retinoblastoma protein (Rb) normally restrains progression past this point by binding and inhibiting a transcription factor required for S-phase genes; phosphorylation of Rb by a cyclin-CDK complex releases this brake, and this release is the actual molecular event that commits the cell to divide. A

\text{DNA damage sensed before or during S phase activates p53, which halts the cycle at G1/S.}

p53 accumulates in response to DNA damage signals and acts as a transcription factor, inducing a CDK inhibitor that blocks the cyclin-CDK activity Step 1 depends on; this pauses the cycle at G1/S, giving repair machinery time to act before the genome is copied. A

\text{G2/M checkpoint: verifies that DNA replication is complete and undamaged before mitosis begins.}

Entering mitosis with incompletely replicated or still-damaged DNA would risk segregating broken or partial chromosomes to daughter cells; this checkpoint uses a related damage-and-completion-sensing pathway to block activation of the mitotic cyclin-CDK complex until replication and repair are verified complete. A

\text{Spindle assembly checkpoint (SAC): verifies that every chromosome is correctly attached to spindle fibres from both poles before anaphase begins.}

An unattached or incorrectly attached kinetochore (the protein structure at a chromosome's centromere where spindle fibres attach) generates a "wait" signal that blocks activation of the enzyme complex required to trigger sister-chromatid separation; a single unattached chromosome anywhere in the cell is sufficient to halt anaphase for the entire cell. B

\text{Loss of any checkpoint's sensing or signalling components permits division to proceed despite an unresolved error, propagating that error to daughter cells.}

Because each checkpoint is the only barrier preventing progression past its specific point in the presence of a specific class of error, a mutation that disables a checkpoint component (most commonly p53 itself) removes that barrier entirely, rather than merely weakening it — a binary loss of surveillance rather than a graded one, and the direct mechanistic link to this result's role in cancer (Discussion). A

Result

\text{G1/S} \to \text{S} \to \text{G2/M} \to \text{Mitosis (SAC)} \to \text{Anaphase, each gate blocking progression until its specific error condition is cleared}

Reading. The cell cycle is not simply a fixed sequence of phases; it is that sequence overlaid with a small number of surveillance gates, each capable of halting progression at a specific point until a specific class of problem — unreplicated or damaged DNA, or a misattached chromosome — has been resolved.

Scope. Applies to the eukaryotic cell cycle generally; the specific molecular players named here (p53, Rb, the SAC) are the best-characterised examples, but the general principle — a sensor gating a CDK-dependent transition — extends to additional, less extensively studied checkpoints.

Corollaries & converses

oncogenes-tumour-suppressors' central example of a tumour suppressor is p53 itself (Step 2); its very high mutation frequency across human cancers is a direct, measurable consequence of how much protection a single checkpoint gene provides once lost.
clonal-evolution-of-tumours' entire premise — that a population of cells can accumulate mutations and be selected on the basis of proliferative advantage — depends on checkpoint failure having already occurred; an intact checkpoint system would eliminate or arrest most such mutant cells before they could found a growing clone.
Converse: a tumour cell line found to tolerate significant chromosome mis-segregation without arresting can be inferred to have a defective spindle assembly checkpoint (Step 4), even without directly sequencing its checkpoint genes.

Fails without

Drop checkpoint reversibility (imagine arrest were permanent regardless of whether the underlying problem is repaired): a cell with a transient, fully repairable problem would be needlessly eliminated rather than resuming division once fixed, inconsistent with the observed capacity of checkpoint-arrested cells to re-enter the cycle after successful DNA repair.
Drop specific damage-sensing (imagine checkpoints triggered arrest independent of actual DNA or spindle status): the cell cycle would arrest as often in undamaged cells as in damaged ones, and checkpoints would provide no net protection against propagating a genuine error — precisely the failure mode that follows when checkpoint genes such as p53 are themselves mutated (oncogenes-tumour-suppressors), a root mechanistic cause of cancer (hallmarks-of-cancer).

Common errors

Treating checkpoints as steps of the cell cycle itself (like a phase), rather than as surveillance mechanisms that monitor and can halt progression between phases.
Assuming a single unattached chromosome is a minor problem the spindle checkpoint can safely ignore; Step 4 establishes that even one unattached kinetochore is sufficient to arrest the entire cell.
Confusing checkpoint arrest (reversible, pending resolution of the triggering problem) with apoptosis (permanent; Hypotheses, third assumption) — the two are related but mechanistically and functionally distinct outcomes of DNA damage signalling.
Assuming loss of a single checkpoint is, by itself, sufficient to cause cancer; hallmarks-of-cancer establishes that a tumour must additionally acquire several other capabilities before becoming a clinically significant cancer, of which checkpoint evasion is only one.

Discussion

p53 is frequently described as "the guardian of the genome," a description that follows directly from Step 2 and Step 5: because so many distinct forms of cellular stress converge on p53 as their common downstream effector, and because its loss removes that convergent safeguard entirely rather than partially, mutations inactivating p53 are found in roughly half of all human cancers — the single most commonly mutated gene across human cancer as a whole.

The G1/S and G2/M checkpoints and the spindle assembly checkpoint are mechanistically distinct systems (different sensors, different downstream targets) that happen to converge on the shared strategy of blocking cyclin-CDK activity; this is a case of convergent regulatory design rather than a single unified checkpoint mechanism operating identically at every point in the cycle.

Common misconception: that checkpoint failure alone is sufficient to cause cancer. As hallmarks-of-cancer and clonal-evolution-of-tumours both establish, checkpoint loss removes a barrier to accumulating further mutations and to uncontrolled division, but a clinically significant tumour requires the additional acquisition of several further capabilities beyond checkpoint evasion alone.

Worked examples

\text{A cell is irradiated, causing DNA double-strand breaks, while in G1.}

DNA damage sensors detect the breaks and activate p53 (Step 2), which induces a CDK inhibitor; this blocks the Rb-releasing phosphorylation event of Step 1, halting the cell at the G1/S checkpoint until the breaks are repaired. If damage is too extensive to repair, sustained p53 signalling instead favours the cell's elimination by apoptosis rather than resumption of the cycle. A

\text{The same cell carries a mutation that inactivates both copies of its p53 gene.}

With no functional p53 to sense the damage and halt the cycle (Step 5), the cell proceeds into S phase and replicates its genome despite the unrepaired double-strand breaks, propagating the resulting mutations (and any resulting chromosomal rearrangements) to both daughter cells. A

\text{p53 intact: damage} \to \text{arrest or apoptosis} \qquad \text{p53 lost: damage} \to \text{unchecked replication} \to \text{mutation propagated}

Reading. The presence or absence of a single functional checkpoint gene is the entire difference between damage being contained at the cell in which it occurred and damage being passed on to an expanding lineage of daughter cells.

Scope. The identical logic applies to G2/M checkpoint loss (unrepaired damage entering mitosis) and spindle checkpoint loss (mis-segregated chromosomes entering daughter cells), each propagating a different class of genomic error.

Problems

Explain why a mutation that disables the spindle assembly checkpoint, but leaves the G1/S and G2/M checkpoints intact, can still result in daughter cells with an abnormal chromosome number (aneuploidy).
Solution
The G1/S and G2/M checkpoints monitor DNA replication and damage, not chromosome attachment to the spindle; they cannot detect or prevent a chromosome segregation error. Only the spindle assembly checkpoint (Step 4) specifically monitors kinetochore attachment. If it is disabled, a cell can proceed through anaphase and divide even with one or more chromosomes unattached or mis-attached, producing daughter cells that gain or lose whole chromosomes despite both other checkpoints functioning normally.
A tumour is found to have cells that continue dividing despite carrying extensive unrepaired DNA damage. Given Step 2 and Step 5, what is the most likely status of that tumour's p53 pathway, and why?
Solution
The most likely explanation is that the p53 pathway is disabled, either by mutation of p53 itself or of a component that normally activates it. Step 2 establishes that functional p53 halts the cycle at G1/S in response to DNA damage; Step 5 establishes that loss of this sensing capacity is a binary failure that permits division to continue despite unresolved damage. Continued division in the presence of extensive damage is therefore strong indirect evidence of p53 pathway loss, consistent with p53's very high mutation frequency across human cancers (Discussion).
Distinguish, using the Hypotheses, between what happens to a cell when a checkpoint delays the cycle versus when p53 signalling instead triggers apoptosis.
Solution
Checkpoint delay (Hypotheses, third assumption) is a reversible arrest: cycle progression is blocked only until the specific triggering problem (unreplicated DNA, damage, or a misattached chromosome) is resolved, after which the block is lifted and the cycle resumes normally. Apoptosis is not reversible arrest but permanent elimination of the cell, triggered when p53 signalling is sufficiently prolonged or intense to indicate that the damage is unlikely to be repairable — a qualitatively different outcome of the same underlying p53 pathway, not simply a longer version of checkpoint arrest.